Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction: pulmonary manifestations contribute significantly to morbidity and mortality of idiopathic inflammatory myopathies; such diseases encompass two large entities such as polymyositis (PM) and dermatomyositis (DM), which are a heterogeneous group of systemic autoimmune diseases, where the muscle is the target of an inappropriate immune-mediated destruction. Its main feature is muscle weakness and identification of underlying inflammation on muscle biopsy. Although the main target organ is skeletal muscle, skin and lungs, among other organs, are often affected by what are considered inflammatory myopathies systemic diseases. Pulmonary involvement is increasingly recognized as a serious complication and a frequent cause of morbidity and mortality in these diseases. Complications can mention pulmonary aspiration pneumonia, to hypoventilation, interstitial lung disease and deserves special mention spontaneous pneumomediastinum in patients with a previous diagnosis of both polymyositis (PM) and dermatomyositis (DM) who have reported around about 3 cases worldwide. The spontaneous pneumomediastinum (NE) is a clinical entity of unknown origin and benign that affects especially, but not exclusively, young people or individuals, it is sometimes explained by alveolar rupture caused by a peripheral parenchymal interstitial diseases producing honeycombing, without having a previous history of chest trauma. Case study: 52 year old female patient, single, residing in Guaranda (Province of Bolivar), with clinical history of dermatomiositosis (DM), diagnosed one month ago at the Reumotology Service of this Hospital and the moment was recieving prednisone 10 mg and 5 mg and 250 mg of chloroquine per day and 50mg/day of azatriopine.
REFERENCIAS BIBLIOGRÁFICAS
L. De Prado Prieto, R. Triano Sánchez y A. García Vadillo.
Afectación Pulmonar que Simula un Tumor como Manifestación Inicial de Polimiositis. Situaciones Clínicas Colmenar, Madrid- España. SEMERGEN, 2009; 35(1):49-50
J. Ramón de Dios, A. López De Goikoetxea, J.C. Vesga, L. Tómas, V. Zorrilla, J. L. Lobo. Neumomediastino y Daño Alveolar Difuso. Afección Pulmonar Severa por Dermatomiositis. Reumatol Clin. 2009; 5(2): 76-79
F. Maupeou, H. Chiavassa Gandois, J. Giron, L Zabraniecki, N. No, B. Proporcionada, JJ Railhac. El neumomediastino espontáneo y dermatomiositis: enfoque fisiopatológico por imágenes. Journal of Hospital Infection 2003; 20(6c): 965-968
A. José Rodrígues, M. Jacomelli, P. R. Scordamaglio, V. Rossi Figueiredo. Spontaneous pneumomediastinum associated with laryngeal lesions and tracheal ulcer in dermatomyositis. Rev. Bras. Reumatol 2012; 52 (5): 796-799
B. Le Goff, P. Cherín, A. Cantagrel, M. Gayraud, E. Hachulla, F. Laborde, T. Papo, J. Sibilia, L. Zabraniecki, P. Ravaud, X. Puechal. Pneumomediastinum in Interstitial Lung Disease Associated With Dermatomyositis and Polymyositis. American College of Rheumatology. Arthritis & Rheumatism (Arthritis Care & Research) 2009; 61: 108-118
A. Selva O´ Callaghan, E. Trallero Araguás. Miopatías inflamatorias. Dermatomiositis, polimiositis y miositis con cuerpos de inclusión. Reumatol Clin. 2008;4(5): 197-206
Mauroka H, Honda S, Takeo M, Kitazato H, Hanai N, Ayukawa R, Tanaka K, Fukuda T, Aizawa H. A case of polymyositis complicated with interstitial pneumonitis and pneumomediastinum. Mod Rheumatol 2006; 16(1): 55-57
Shimamoto K, Ozaki Y, Amuro H, Son Y, Ota-imamura M, Tanijiri T, Yokoi T, Yagi Y, Ito T, Yonezu S, Fukuhara S. Three cases of polymyositis/dermatomyositis complicated by pneumomediastinum. Nihon Rinsho Meneki Gakkai Kaishi 2008;31(1): 56-61
P Sandhya, Shyamkumar Nidugala Keshava, Debashish Danda, Prasanta Padhan, John Mathew, Sridhar Gigikote. Pneumorrhachis and pneumomediastinum in connective tissue disease related interstitial lung disease: case series from a tertiary care teaching hospital in South India. Rheumatology International 2012;32(5):
-1419
Kameda H, Takeuchi T. Recent advances in the treatment of interstitial lung disease in patients with polymyositis/ dermatomyositis. Endocrine, Metabolic & Immune Disorders 2006; 15(7): 409-415
Tong SQ, Shi XH, Su JM, Zhao Y, Zhang Fc. Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis. Zhonghua Yi Xue Za Zhi. 2006; 86(9): 624-627
Manuel Caceres, MD, Syed Z, MD, Rebecca Braud, BS, Darryl Weiman, MD, Edward Garrett Jr, MD. Spontaneous Pneumomediastinum: A Comparative Study and Review of the Literature. Ann Thorac Surg. 2008; 86(3): 962-966. doi:10.1016/j. athoracsur.2008.04.067
M. Restrepo Escobar, L. González Naranjo, A. Pantoja Márquez, L. Ramírez Gómez, G. Vásquez Duque. Complicaciones pulmonares de las miopatías inflamatorias idiopáticas: a propósito de un caso con miopatía diafragmática. Revista Colombiana de Reumatología 2009; 16(3): 301-309
William W. Douglas, Henry D. Tazellar, Thomas E. Hartman, Robert P. Hartman, Paul A. Decker, Darrel R. Schroeder, and Jay H. Ryu. Polymyositis Dermatomyositis associated Interstitial Lung Disease. Am J Respir Crit Care Med 2001; 164(5): 1182-1185
E.H. Kang, E.B. Lee, K.C. Shin, C.H. Im, D.H, Chung, S.K.
Han and Y.W. Song. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopatihc dermatomyositis. Rheumatology 2005; 44: 1282-1286
C. Korkmaz, R. Ozkan, M. Akay, T. Hakan. Pneumomediastinum and subcutaneous emphysema associated with dermatomyositis. Rheumatology 2001; 40: 476-478
Masrouha K.Z, Kanj N, Uthman I. Late on set pneumomediastinum in dermato myositis. Rheumatol Int 2009; 30(2): 291-292
Neves FS, Shinjo SK, Carvalho JF, Levy Neto M, Borges CTL. Spontaneous pneumomediastinum and dermatomyositis may be a not so rare association: report of a case and review of the literature. Clin Rheumatol. 2007;26:105–7
Targoff IN. Autoantibodies and Their Significance in Myositis. Current Rheumatology Reports. 2008; 10: 333-340
Leslie KO, Trahan S, Gruden J. Pulmonary Pathology of the Rheumatic Diseases. Seminars Respirat Crit Care Med 2007; 28: 369-378
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.